-
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE HEMOSTASIS-RELATED COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING MYOMECTOMY: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
CAN LINKED CLAIMS-EHR DATA BE USED TO GENERATE SYNTHETIC DATA? AN EVALUATION OF THE MARKETSCAN-VERADIGM LINKED CLAIMS + EHR DATABASE
Mar 18, 2026, 21:38 PM -
A LIKELIHOOD-AUGMENTED VIRTUAL INCONSISTENCY-ADJUSTED ANALYSIS FRAMEWORK FOR ASSESSING ROBUSTNESS IN A STAR-SHAPED NETWORK META-ANALYSIS
Mar 18, 2026, 21:38 PM -
CLINICAL AND ECONOMIC IMPACT OF FARICIMAB-TREATED DIABETIC MACULAR EDEMA: A LINKED ANALYSIS OF ADMINISTRATIVE CLAIMS AND IRIS REGISTRY DATA
Mar 18, 2026, 21:38 PM -
BREAK EVEN ANALYSIS FOR CONTRACEPTION PRESCRIBING SERVICES IN COMMUNITY PHARMACIES
Mar 18, 2026, 21:38 PM -
WHAT MATTERS MOST TO PATIENTS IN WARFARIN MODELS OF CARE: A QUALITATIVE STUDY
Mar 18, 2026, 21:38 PM -
YEARS LOST: QUANTIFYING THE HUMAN COST OF DELAYED GENETIC DIAGNOSIS
Mar 18, 2026, 21:38 PM -
GEOGRAPHIC DISPARITIES IN TREATMENT ACCESS FOR TEXAS MEDICAID PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Mar 18, 2026, 21:38 PM -
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS AND RISK OF PARKINSON’S DISEASE IN PATIENTS WITH OBESITY
Mar 18, 2026, 21:38 PM -
COMBINING PLASMA COLLECTION WITH DEMAND DIVERSION TO ACHIEVE IMMUNOGLOBULIN SELF-SUFFICIENCY IN CANADA
Mar 18, 2026, 21:38 PM -
STRUCTURAL HETEROGENEITY IN HEALTH ECONOMIC MODELLING APPROACHES FOR HCV AND HDV DIAGNOSTICS: NEED FOR HARMONIZATION
Mar 18, 2026, 21:38 PM -
DECODING THE PREDICTIVE ROLE OF COMPLETE RESPONSE/REMISSION RATE (CR) FOR OVERALL SURVIVAL (OS) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Mar 18, 2026, 21:38 PM -
CHANGES IN PAIN AND STIFFNESS EXPERIENCED BY PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN THE MANEUVER PHASE 3 TRIAL: INSIGHTS FROM EXIT INTERVIEWS
Mar 18, 2026, 21:38 PM -
A DESCRIPTIVE COMPARISON OF U.S. MEDICARE IRA NEGOTIATED PRICES AND AVERAGE MFN BENCHMARKS FOR PART D DRUGS
Mar 18, 2026, 21:38 PM -
ADVANCING CLINICAL DEVELOPMENT AND EVIDENCE GENERATION THROUGH CAUSAL AI: A TARGETED REVIEW OF APPLICATIONS AND IMPLICATIONS FOR REGULATORY-GRADE EVIDENCE
Mar 18, 2026, 21:38 PM -
MODELING RARE EVENTS IN HEALTH INTERVENTION: AN APPLICATION FROM THE DEPARTMENT OF WAR DATASET
Mar 18, 2026, 21:38 PM -
IMPACT OF GLP-1 RECEPTOR AGONIST (GLP-1 RAS) PERSISTENCE VERSUS DISCONTINUATION ON CARDIOMETABOLIC MEASURES IN POLYCYSTIC OVARY SYNDROME (PCOS) OVER A TWO-YEAR FOLLOW-UP
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR LONG-ACTING PREP ADMINISTRATION AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
BENCHMARKING GENERATIVE AI TOOLS FOR COST-EFFECTIVENESS ANALYSIS (CEA) MODEL INPUT CURATION: A COMPARATIVE EVALUATION OF LARGE LANGUAGE MODELS
Mar 18, 2026, 21:09 PM -
ECONOMIC VALUE OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSIS HIGHLIGHTING METHODOLOGICAL GAPS
Mar 18, 2026, 21:09 PM
